2
Participants
Start Date
June 15, 2010
Primary Completion Date
September 13, 2011
Study Completion Date
September 13, 2011
Arterial Spin Labeling Blood Flow Magnetic Resonance Imaging
Performed at baseline, 2 weeks upon initiation of therapy, after cycle 2 and/or cycle 4 of therapy, and at the end of treatment
Beth Israel Deaconess Medical Center, Boston
Dana-Farber Cancer Institute, Boston
Collaborators (1)
Dana-Farber Cancer Institute
OTHER
Amgen
INDUSTRY
Beth Israel Deaconess Medical Center
OTHER